Clinical outcome in a Norwegian cohort of patients with chronic recurrent multifocal osteomyelitis

Scand J Rheumatol. 2015;44(6):513-4. doi: 10.3109/03009742.2015.1055514. Epub 2015 Aug 24.

Authors

A Johnsson¹, B Flatø¹, P K Knudsen², V Lilleby¹

Affiliations

¹ a Department of Rheumatology , Oslo University Hospital , Oslo , Norway.
² b Department of Pediatrics , Oslo University Hospital , Oslo , Norway.

PMID: 26312400
DOI: 10.3109/03009742.2015.1055514

No abstract available

Publication types

Letter

MeSH terms

Adrenal Cortex Hormones / therapeutic use*
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Child
Cohort Studies
Female
Humans
Male
Methotrexate / therapeutic use*
Norway / epidemiology
Osteomyelitis / drug therapy*
Osteomyelitis / epidemiology
Recurrence
Retrospective Studies
Treatment Outcome
Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

Adrenal Cortex Hormones
Anti-Inflammatory Agents, Non-Steroidal
Tumor Necrosis Factor-alpha
Methotrexate

Supplementary concepts

Chronic recurrent multifocal osteomyelitis